Press release
Athira Pharma, Inc. (NASDAQ: ATHA) Investor Notice: Update in Lawsuit
A lawsuit is pending for certain investors in Athira Pharma, Inc. (NASDAQ: ATHA) shares.
If you purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On June 25, 2021, a lawsuit was filed for investors in shares of Athira Pharma, Inc over alleged Securities Laws Violations. The plaintiff claims the Registration Statement and that between September 18, 2020 and June 17, 202, the defendants made materially false and misleading statements and omitted to state that Dr. Kawas had published research papers containing improperly altered images while she was a graduate student, that this purported research was foundational to Athira's efforts to develop treatments for Alzheimer's because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer's, that as a result, Athira's intellectual property and product development for the treatment of Alzheimer's was based on invalid research, and that as a result of the foregoing, the defendants' positive statements about Athira's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
On January 7, 2022, a consolidated amended complaint was filed and on March 8, 2022, the defendants filed their motion to dismiss the case.
On July 29, 2022, the Court issued an Order granting in part and denying in part Defendants' Motion to Dismiss.
Those who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and should contact the Shareholders Foundation. About Shareholders Foundation, Inc.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Athira Pharma, Inc. (NASDAQ: ATHA) Investor Notice: Update in Lawsuit here
News-ID: 2881707 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
Investigation announced for Investors in shares of Endeavour Mining plc (OTC: ED …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Endeavour Mining plc.
Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Endeavour Mining plc directors breached their fiduciary duties and caused damage to the company and its shareholders.
United…
More Releases for Athira
Alzheimer’s Disease Pipeline Market to expand $6.3 billion at a CAGR of +5% Du …
Alzheimer's Disease is a mental problem that gradually obliterates memory and thinking abilities and, in the end, the capacity to complete the least difficult assignments. In a great many people with the illness, those with the late-beginning sort side effects initially show up in their mid-60s.
The global market for Alzheimer's disease treatment should grow from $4.8 billion in 2022 to $6.3 billion by 2027 with a CAGR of +5% during…
Investigation announced for Investors in shares of Athira Pharma, Inc. (NASDAQ: …
An investigation was announced on behalf of current long-term investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA) concerning potential breaches of fiduciary duties by certain directors of Athira Pharma, Inc.
Investors who are current long term investors in Athira Pharma, Inc. (NASDAQ: ATHA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Deadline on August 24th coming up in Lawsuit for Investors in shares of Athira P …
A deadline is coming up on August 24, 2021 in the lawsuit filed for certain investors of Athira Pharma, Inc. (NASDAQ: ATHA) over alleged securities laws violations by Athira Pharma, Inc.
Investors who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and there are strict and short deadlines running. Deadline: August 24, 2021. NASDAQ: ATHA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA)
An investor, who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA), filed a lawsuit over alleged violations of Federal Securities Laws by Athira Pharma, Inc.
Investors who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and for certain investors are short and strict deadlines running. Deadline: August 24, 2021. NASDAQ: ATHA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Bothell, WA based Athira…
